Relapsing Parvovirus B19 Infection after Intravenous Immunoglobulin in Renal Transplant Recipient: A Case Report

Authors

  • Rabin Nepali Department of Nephrology, Maharajgunj Medical Campus, Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal Author
  • Pawan R Chalise Department of Urology and Kidney Transplant Surgery, Maharajgunj Medical Campus, Tribhuvan University Teaching Hospital, Institute of Medicine, Maharajgunj, Kathmandu, Nepal Author
  • Dibya Singh Shah Department of Nephrology, Maharajgunj Medical Campus, Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal Author

DOI:

https://doi.org/10.59779/jiomnepal.1270

Keywords:

Parvovirus B19, intravenous immunoglobulin, renal transplant, relapse

Abstract

Parvovirus B19 has special affinity to erythroid progenitor cells leading to destruction and inhibition of erythropoiesis. One of its presentations is pure red cell aplasia in patients receiving immunosuppressive medications after organ transplantation. Intravenous immunoglobulin (IVIG) and reduction of immunosuppressive medication has been used for treatment but the effects of IVIG may be temporary. Here we present a case of Relapsing infection due to Parvovirus B19 after IVIG in a renal transplant recipient in Nepal. This case shows that in renal transplant patients presenting with anemia and low reticulocyte count, Parvovirus B19 infection should be suspected. Treatment with IVIG has good results but there may be relapse of infection.

Downloads

Published

2023-08-31

How to Cite

Nepali, R., Chalise, P. R., & Shah, D. S. (2023). Relapsing Parvovirus B19 Infection after Intravenous Immunoglobulin in Renal Transplant Recipient: A Case Report. Journal of Institute of Medicine Nepal, 45(2), 64-66. https://doi.org/10.59779/jiomnepal.1270

Most read articles by the same author(s)

1 2 > >> 

Similar Articles

21-30 of 125

You may also start an advanced similarity search for this article.